Indian-made pneumonia vaccine is set to break Big Pharma’s hold on Gavi funds
NewsApril 22, 2019
By the end of the year, a new pneumonia vaccine produced by Serum Institute of India is set to enter the market at a much lower price than Gavi currently pays. Key vaccine actors call this a “game changer” that could reduce prices and save children’s lives.
The rest of the content is only available for subscribers.